Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial

Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target.

The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning.

Eli Lilly‘s stock rose 2.1% in premarket trading.

Novo is exploring additional trials to test CagriSema, including higher-dose combinations, it said.

This is breaking news. Please refresh for updates.

Source

World

Dow futures drop 250 points as Trump raises tariffs again, sowing confusion: Live updates

February 23, 2026

Traders work on the floor of the New York Stock Exchange (NYSE) on February 13, 2026 in New York City. Spencer Platt | Getty Images U.S. stock futures fell on Monday after President Donald Trump said he’s raising his global tariffs to 15% following the Supreme Court’s decision to strike down the president’s “reciprocal” tariffs. […]

Finland’s IQM to become one of Europe’s first listed quantum companies at .8 billion valuation

World

Finland’s IQM to become one of Europe’s first listed quantum companies at $1.8 billion valuation

February 23, 2026

European startup IQM is aiming to build powerful quantum computers to rival the likes of Google and IBM. IQM Finland-based quantum computing startup IQM announced plans Monday to become one of Europe’s first publicly listed companies in the sector. IQM will merge with special purpose acquisition company (SPAC), Real Asset Acquisition Corp. (RAAQ) as part […]

World

Treasury yields hold steady as investors weigh new Trump tariffs

February 23, 2026

U.S. Treasury yields were little changed to start the week as investors weighed President Donald Trump’s latest tariffs, after the Supreme Court struck down much of the duties on Friday. At 6:03 a.m. ET, the 10-year Treasury yield was down 1 basis point at 4.075%. The 30-year Treasury bond yield was also less than 1 basis point lower […]